Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -12.954% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COc1ccc(-c2cc(C(=O)Nc3c(C)nn(Cc4ccccc4Cl)c3C)no2)cc1
[b] CC(C)N(CCNC(=O)C1CCC(=O)N1Cc1ccc(F)cc1)Cc1ccccc1
Answer: b. CC(C)N(CCNC(=O)C1CCC(=O)N1Cc1ccc(F)cc1)Cc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N(CCNC(=O)C1CCC(=O)N1Cc1ccc(F)cc1)Cc1ccccc1
CC(C)N(CCNC(=O)C1CCC(=O)N1Cc1ccc(F)cc1)Cc1ccccc1
N-[2-[benzyl(propan-2-yl)amino]ethyl]-1-[(4-fluorophenyl)methyl]-5-oxopyrrolidine-2-carboxamide